BIG PHARMA EARNINGS WATCH: NOVARTIS & JOHNSON & JOHNSON
Jul 20, 2023
Big Pharma Giants Kick Off Q2 Earnings On Heels of July Price Hikes This week,… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA WATCH: HHS SECRETARY WARNS COVID-19 VACCINE MAKERS OVER “PRICE-GOUGING BEHAVIOR”
Jul 14, 2023
Becerra Encourages Manufacturers to Set “Reasonable” Prices on Upcoming… Read More
BIG PHARMA WATCH: BIG PHARMA ALREADY INCREASING PRICES ON NEW RSV VACCINES TO BOOST PROFITS
Jul 13, 2023
Manufacturers Increasing Prices in Lockstep to Raise Prices Across New Drug… Read More
BIG PHARMA WATCH: BIG PHARMA EXPOSED FOR CONTINUING TO HIKE PRICES FASTER THAN RATE OF INFLATION
Jun 16, 2023
HHS & CMS Announce New Penalties That Help Hold Brand Name Drug Companies… Read More
DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS OVER $40 BILLION IN JUST ONE YEAR
May 23, 2023
New Analysis Highlights Urgency to Hold Big Pharma Accountable for Egregious… Read More
DOSE OF REALITY: BIG PHARMA TAX AVOIDANCE PRACTICES COME UNDER SCRUTINY IN SENATE FINANCE HEARING
May 12, 2023
Report Finds Big Pharma Games the System to Avoid Paying U.S. Taxes While… Read More
THEY SAID IT! LAWMAKERS SLAM BIG PHARMA CEOS FOR EGREGIOUS PRICING OF BRAND NAME INSULINS
May 12, 2023
Brand Name Drug Giants Refuse to Rule Out Future Insulin Price Hikes On… Read More
DOSE OF REALITY: SENATORS MUST HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS INSULIN PRICING PRACTICES
May 9, 2023
Lawmakers Have Opportunity to Grill Big Pharma Executives on Tactics Like… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, MODERNA, ELI LILLY, NOVARTIS, GLAXOSMITHKLINE, ROCHE, AMGEN
May 9, 2023
Brand Name Drug Companies Continue to Hike Prices and Post Record Profits… Read More
BIG PHARMA EARNINGS WATCH: MERCK, SANOFI, BRISTOL MYERS SQUIBB, ABBVIE AND ASTRAZENECA
May 3, 2023
More Big Pharma Giants Surpass Wall Street Expectations, Buoyed By Egregious… Read More
BIG PHARMA WATCH: BIG PHARMA SPENT $8.1 BILLION ON ADS PUSHING HIGH-PRICED BRAND NAME PRESCRIPTION DRUGS IN 2022
May 1, 2023
Big Pharma Spending Binge Underscores Bipartisan Support for List Price… Read More
DOSE OF REALITY: LIST PRICE TRANSPARENCY WILL HELP HOLD BIG PHARMA ACCOUNTABLE AND LOWER PRESCRIPTION DRUG PRICES FOR PATIENTS
Apr 25, 2023
Congress Should Advance Bipartisan, Market-Based Measures to Increase… Read More